|
Volumn 13, Issue 2, 2002, Pages
|
New drugs for Huntington's disease
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCOSAHEXAENOIC ACID;
ETHYLICOSAPENTAENOIC ACID;
GAMMA LINOLENIC ACID;
ICOSAPENTAENOIC ACID;
NEW DRUG;
REMACEMIDE;
UBIDECARENONE;
UNCLASSIFIED DRUG;
UNSATURATED FATTY ACID;
VALPROIC ACID;
APOPTOSIS;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
DISEASE COURSE;
DRUG EFFICACY;
HUMAN;
HUNTINGTON CHOREA;
NEUROPROTECTION;
NUCLEOTIDE REPEAT;
PRIORITY JOURNAL;
SHORT SURVEY;
VALIDATION PROCESS;
|
EID: 0037060455
PISSN: 09594965
EISSN: None
Source Type: Journal
DOI: 10.1097/00001756-200202110-00001 Document Type: Short Survey |
Times cited : (11)
|
References (16)
|